JP2016521752A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016521752A5 JP2016521752A5 JP2016519661A JP2016519661A JP2016521752A5 JP 2016521752 A5 JP2016521752 A5 JP 2016521752A5 JP 2016519661 A JP2016519661 A JP 2016519661A JP 2016519661 A JP2016519661 A JP 2016519661A JP 2016521752 A5 JP2016521752 A5 JP 2016521752A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- composition according
- burkholderia
- composition
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241001453380 Burkholderia Species 0.000 claims 8
- 241000124008 Mammalia Species 0.000 claims 4
- 102000016911 Deoxyribonucleases Human genes 0.000 claims 3
- 108010053770 Deoxyribonucleases Proteins 0.000 claims 3
- 241000371430 Burkholderia cenocepacia Species 0.000 claims 2
- 206010073031 Burkholderia infection Diseases 0.000 claims 2
- 201000003883 Cystic fibrosis Diseases 0.000 claims 2
- 239000003242 anti bacterial agent Substances 0.000 claims 2
- 239000000427 antigen Substances 0.000 claims 2
- 102000036639 antigens Human genes 0.000 claims 2
- 108091007433 antigens Proteins 0.000 claims 2
- 239000012634 fragment Substances 0.000 claims 2
- 239000004599 antimicrobial Substances 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 238000001727 in vivo Methods 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361834846P | 2013-06-13 | 2013-06-13 | |
| US61/834,846 | 2013-06-13 | ||
| PCT/US2014/042201 WO2014201305A1 (en) | 2013-06-13 | 2014-06-12 | Compositions and methods for the treatment of burkholderia infections |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017109356A Division JP2017143841A (ja) | 2013-06-13 | 2017-06-01 | Ｂｕｒｋｈｏｌｄｅｒｉａ感染の処置のための組成物および方法 |
| JP2018187557A Division JP6832901B2 (ja) | 2013-06-13 | 2018-10-02 | Ｂｕｒｋｈｏｌｄｅｒｉａ感染の処置のための組成物および方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016521752A JP2016521752A (ja) | 2016-07-25 |
| JP2016521752A5 true JP2016521752A5 (enExample) | 2017-07-13 |
Family
ID=51177157
Family Applications (8)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016519661A Pending JP2016521752A (ja) | 2013-06-13 | 2014-06-12 | Ｂｕｒｋｈｏｌｄｅｒｉａ感染の処置のための組成物および方法 |
| JP2017109356A Ceased JP2017143841A (ja) | 2013-06-13 | 2017-06-01 | Ｂｕｒｋｈｏｌｄｅｒｉａ感染の処置のための組成物および方法 |
| JP2018187557A Active JP6832901B2 (ja) | 2013-06-13 | 2018-10-02 | Ｂｕｒｋｈｏｌｄｅｒｉａ感染の処置のための組成物および方法 |
| JP2019223668A Withdrawn JP2020037595A (ja) | 2013-06-13 | 2019-12-11 | Ｂｕｒｋｈｏｌｄｅｒｉａ感染の処置のための組成物および方法 |
| JP2022088322A Pending JP2022116236A (ja) | 2013-06-13 | 2022-05-31 | Ｂｕｒｋｈｏｌｄｅｒｉａ感染の処置のための組成物および方法 |
| JP2023041844A Ceased JP2023072074A (ja) | 2013-06-13 | 2023-03-16 | Ｂｕｒｋｈｏｌｄｅｒｉａ感染の処置のための組成物および方法 |
| JP2024034820A Ceased JP2024060001A (ja) | 2013-06-13 | 2024-03-07 | Ｂｕｒｋｈｏｌｄｅｒｉａ感染の処置のための組成物および方法 |
| JP2025078757A Pending JP2025122007A (ja) | 2013-06-13 | 2025-05-09 | Ｂｕｒｋｈｏｌｄｅｒｉａ感染の処置のための組成物および方法 |
Family Applications After (7)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017109356A Ceased JP2017143841A (ja) | 2013-06-13 | 2017-06-01 | Ｂｕｒｋｈｏｌｄｅｒｉａ感染の処置のための組成物および方法 |
| JP2018187557A Active JP6832901B2 (ja) | 2013-06-13 | 2018-10-02 | Ｂｕｒｋｈｏｌｄｅｒｉａ感染の処置のための組成物および方法 |
| JP2019223668A Withdrawn JP2020037595A (ja) | 2013-06-13 | 2019-12-11 | Ｂｕｒｋｈｏｌｄｅｒｉａ感染の処置のための組成物および方法 |
| JP2022088322A Pending JP2022116236A (ja) | 2013-06-13 | 2022-05-31 | Ｂｕｒｋｈｏｌｄｅｒｉａ感染の処置のための組成物および方法 |
| JP2023041844A Ceased JP2023072074A (ja) | 2013-06-13 | 2023-03-16 | Ｂｕｒｋｈｏｌｄｅｒｉａ感染の処置のための組成物および方法 |
| JP2024034820A Ceased JP2024060001A (ja) | 2013-06-13 | 2024-03-07 | Ｂｕｒｋｈｏｌｄｅｒｉａ感染の処置のための組成物および方法 |
| JP2025078757A Pending JP2025122007A (ja) | 2013-06-13 | 2025-05-09 | Ｂｕｒｋｈｏｌｄｅｒｉａ感染の処置のための組成物および方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20160175440A1 (enExample) |
| EP (1) | EP3008088B1 (enExample) |
| JP (8) | JP2016521752A (enExample) |
| AU (4) | AU2014278037A1 (enExample) |
| CA (1) | CA2915210A1 (enExample) |
| ES (1) | ES2746971T3 (enExample) |
| WO (1) | WO2014201305A1 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2012010793A (es) | 2010-03-29 | 2013-05-09 | Univ Southern California | Composiciones y metodos para la eliminacion de biopeliculas. |
| WO2012034090A1 (en) | 2010-09-09 | 2012-03-15 | University Of Southern California | Compositions and methods for the removal of biofilms |
| US11274144B2 (en) | 2013-06-13 | 2022-03-15 | Research Institute At Nationwide Children's Hospital | Compositions and methods for the removal of biofilms |
| US9745366B2 (en) | 2013-09-23 | 2017-08-29 | University Of Southern California | Compositions and methods for the prevention of microbial infections |
| US11248040B2 (en) | 2013-09-26 | 2022-02-15 | Trellis Bioscience, Llc | Binding moieties for biofilm remediation |
| US10233234B2 (en) | 2014-01-13 | 2019-03-19 | Trellis Bioscience, Llc | Binding moieties for biofilm remediation |
| US10624934B2 (en) | 2014-03-06 | 2020-04-21 | Research Institute At Nationwide Children's Hospital | Prebiotic formulations |
| EP3536168A3 (en) | 2014-03-06 | 2019-10-16 | The Research Institute at Nationwide Children's Hospital | Probiotic formulations and methods for use |
| WO2016154491A1 (en) * | 2015-03-25 | 2016-09-29 | Trellis Bioscience, Llc | Binding moieties for biofilm remediation |
| HK1255383A1 (zh) * | 2015-07-31 | 2019-08-16 | The Research Institute At Nationwide Children's Hospital | 去除生物膜的肽及抗體 |
| EP3365027B1 (en) * | 2015-10-14 | 2022-03-30 | Research Institute at Nationwide Children's Hospital | Hu specific antibodies and their use in inhibiting biofilm |
| AU2018206552C1 (en) * | 2017-01-04 | 2025-04-10 | Research Institute At Nationwide Children's Hospital | DNABII vaccines and antibodies with enhanced activity |
| EP3565834B1 (en) * | 2017-01-04 | 2025-10-22 | The Research Institute at Nationwide Children's Hospital | Antibody fragments for the treatment of biofilm-related disorders |
| US11746136B2 (en) | 2017-03-15 | 2023-09-05 | Research Institute At Nationwide Children's Hospital | Composition and methods for disruption of bacterial biofilms without accompanying inflammation |
| MX2021003838A (es) | 2018-10-05 | 2021-05-27 | Res Inst Nationwide Childrens Hospital | Derivados de proteina hmgb1 para la eliminacion de biopeliculas. |
| US12161701B2 (en) * | 2018-10-05 | 2024-12-10 | Research Institute At Nationwide Children's Hospital | Compositions and methods for enzymatic disruption of bacterial biofilms |
| CA3142272A1 (en) | 2019-06-03 | 2020-12-10 | Research Institute At Nationwide Children's Hospital | Prebiotic formulations for prevention of sepsis and necroenterocolitis induced neurodevelopmental deficiencies |
| US12209118B2 (en) | 2019-07-08 | 2025-01-28 | Research Institute At Nationwide Children's Hospital | Antibody compositions for disrupting biofilms |
| WO2023228443A1 (ja) | 2022-05-24 | 2023-11-30 | 株式会社オクト | バイオフィルムを破壊するための溶液及びその製造方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102497883B (zh) * | 2009-06-03 | 2014-06-11 | 阿尔吉法玛公司 | 用于克服细菌多重抗药性的藻酸盐低聚物 |
| EP2473170B1 (en) * | 2009-09-04 | 2019-06-19 | Horizon Orphan LLC | Use of aerosolized levofloxacin for treating cystic fibrosis |
| MX2012010793A (es) * | 2010-03-29 | 2013-05-09 | Univ Southern California | Composiciones y metodos para la eliminacion de biopeliculas. |
| WO2012034090A1 (en) * | 2010-09-09 | 2012-03-15 | University Of Southern California | Compositions and methods for the removal of biofilms |
-
2014
- 2014-06-12 ES ES14738954T patent/ES2746971T3/es active Active
- 2014-06-12 AU AU2014278037A patent/AU2014278037A1/en not_active Abandoned
- 2014-06-12 JP JP2016519661A patent/JP2016521752A/ja active Pending
- 2014-06-12 EP EP14738954.8A patent/EP3008088B1/en active Active
- 2014-06-12 CA CA2915210A patent/CA2915210A1/en active Pending
- 2014-06-12 WO PCT/US2014/042201 patent/WO2014201305A1/en not_active Ceased
-
2015
- 2015-12-11 US US14/967,228 patent/US20160175440A1/en not_active Abandoned
-
2017
- 2017-06-01 JP JP2017109356A patent/JP2017143841A/ja not_active Ceased
-
2018
- 2018-04-20 AU AU2018202762A patent/AU2018202762C1/en active Active
- 2018-10-02 JP JP2018187557A patent/JP6832901B2/ja active Active
-
2019
- 2019-12-11 JP JP2019223668A patent/JP2020037595A/ja not_active Withdrawn
-
2020
- 2020-05-11 AU AU2020203092A patent/AU2020203092A1/en not_active Abandoned
-
2022
- 2022-05-31 JP JP2022088322A patent/JP2022116236A/ja active Pending
-
2023
- 2023-03-16 JP JP2023041844A patent/JP2023072074A/ja not_active Ceased
- 2023-04-27 AU AU2023202534A patent/AU2023202534A1/en active Pending
-
2024
- 2024-03-07 JP JP2024034820A patent/JP2024060001A/ja not_active Ceased
-
2025
- 2025-05-09 JP JP2025078757A patent/JP2025122007A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016521752A5 (enExample) | ||
| CY1122245T1 (el) | Pd-1 αντισωμα, θραυσμα δεσμευσης αντιγονου αυτου, και ιατρικη εφαρμογη αυτου | |
| PH12019502361A1 (en) | ANTI-N3pGlu AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF | |
| JP2021504412A5 (enExample) | ||
| JP2014221779A5 (enExample) | ||
| CN110366560A (zh) | 抗b7-h4抗体、其抗原结合片段及其医药用途 | |
| EA201891286A1 (ru) | АНТИ-БЕТА-АМИЛОИДНЫЙ ПЕПТИД N3pGlu АНТИТЕЛА И СПОСОБЫ ИХ ПРИМЕНЕНИЯ | |
| JP2015503422A5 (enExample) | ||
| EA201291336A1 (ru) | Замещенные 5-фтор-1н-пиразолопиридины и их применение | |
| JP2015528502A5 (enExample) | ||
| EA201400986A1 (ru) | Фармацевтические композиции, содержащие метформин и ингибитор dpp-4 или ингибитор sglt-2 | |
| JP2013519675A5 (enExample) | ||
| JP2019526543A5 (enExample) | ||
| JP2015504870A5 (enExample) | ||
| EP3846796A4 (en) | Methods of treating cytokine release syndrome | |
| EA201490552A1 (ru) | Холиновая соль замещенного циклобутендиона, обладающая противовоспалительной способностью | |
| EP3573658A4 (en) | ANTI-TNF ANTIBODIES, COMPOSITIONS, AND METHODS FOR TREATMENT OF ACTIVE PSORIATIC ARTHRITIS | |
| IL282827A (en) | Bispecific cd123 x cd3 diabodies for the treatment of hematologic malignancies | |
| JP2014513678A5 (enExample) | ||
| MA50526A (fr) | Cocristaux, compositions pharmaceutiques de ceux-ci, et méthodes de traitement les impliquant | |
| JO3565B1 (ar) | الأجسام المضادة لشبيه الأنجيوبوييتين– 4 وطرق استخدامها | |
| JP2015531397A5 (enExample) | ||
| EA201790590A1 (ru) | Гуманизированное моноклональное антитело, ингибирующее ферментативную активность сосудисто-эндотелиальной липазы | |
| EA202092085A1 (ru) | ТЕРАПЕВТИЧЕСКИЕ АНТИТЕЛА ПРОТИВ sPLA2-GIB И ИХ ПРИМЕНЕНИЕ | |
| EA201992389A1 (ru) | Замещенные n-арилэтил-2-аминохинолин-4-карбоксамиды и их применение |